News
Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...
Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.
Robin Zeng’s high-stakes bets—from quitting his first job to founding CATL—have reshaped the global EV battery market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback